"ASCO 2026: Interim data released for upcoming BRAF and RAS mCRC therapies" was originally created and published by Clinical ...
We live in an increasing data-rich world, where forward-thinking organizations are harnessing the power of analysis to make better decisions. To make this happen, the people who collect and crunch ...
– Breadth of Alto’s pipeline and Precision Psychiatry Platform™ will be highlighted across twelve posters and presentations at the Society of Biological Psychiatry and American Society of Clinical ...
– Alterity’s novel imaging and biomarker approach positions the Company at the forefront of clinical research in MSA – – End-of-Phase 2 FDA Meeting on track for mid-2026 to confirm path forward for ...
Pooled analysis of 24 adults and children with KMT2Ar, NPM1m, or NUP98r acute leukemia who resumed revumenib post-transplant shows favorable outcomes, including a2-year overall survival rate of 90% vs ...
August 11, 2025 - Previous articles in this series have explored identification, preservation, collection, review and production of novel data sources, but I would be remiss if I left out the last, ...
Publication-Only Abstract Title: Cell-based second-generation immunotherapy BC1 in metastatic breast cancer. Publication-Only Abstract Title: Liquid biopsy to stratify metastatic breast cancer ...
Jasper Therapeutics, Inc., a biotechnology company focused on developing briquilimab, an antibody therapy for mast cell-driven diseases, announced several presentations related to briquilimab at the ...
Most white collar jobs involve creating presentations. And this can be a time-consuming, laborious process. Presentations include data points, and ensuring that these data points remain accurate and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results